Objective: To detect the relations of c-erbB-2 oncogene protein, epidermal growth factor receptor (EGFR) and transforming growth factor-β1 (TGF-β1) to the progression or metastasis of pancreatic carcinoma.
Methods: Using streptavidinbiotin complex (SABC) method, c-erbB-2 oncongene protein, we examined immunohistochemically EGFR and TGF-β1 expressions in wax-tissue sections from 10 individuals with normal pancreas (NP), 13 patients with chronic pancreatitis (CP) and 36 patients with pancreatic ductal adenocarcinoma (PC).
Results: The positive expression rates of c-cerbB-2 oncogene protein, EGFR and TGF-β1 in the NP, CP and PC groups were 0, 0, 10%; 7.7%, 7.7%, 7.7%; and 41.7%, 50.0%, 44.4%, respectively. The positive expression rates of the three specific proteins increased more significantly in the PC group than in the NP and CP groups (P <0.05). The individual expression of c-erbB-2, EGFR and TGF-β1 was not related to the age and sex of the patients as well as the site, size and histopathological grade of tumors (P >0.05), but to the clinical stage of tumors (P <0.01). The coexpression rate of the three proteins was 27.8% (10/36). This coexpression in the PC group was correlated with the histopathological grades and clinical stages of tumors (P <0.01).
Conclusion: Detection of c-erbB-2 oncogene protein, EGFR, and TGF-β1 expressions in pancreatic tissue is helpful to judge the malignancy, progression, and metastasis of PC.